How does public research affect industry innovation and entrepreneurship? New evidence

This article addresses the concept of “industrial interests” and examines its role in a topical controversy about a large research grant from a private foundation, the Novo Nordisk Foundation, to the University of Copenhagen. The authors suggest that the debate took the form of a “public trial” where the grant and close(r) intermingling between industry and public research was prosecuted and defended. First, the authors address how the grant was framed in the media. Second, they redescribe the case by introducing new “evidence” that, because of this framing, did not reach “the court.” The article ends with a discussion of some implications of the analysis, including that policy making, academic research, and public debates might benefit from more detailed accounts of interests and stakes.

Download Full-text

Systematic effects in observed parallaxes

International Astronomical Union Colloquium ◽

10.1017/s0252921100073887 ◽

1978 ◽

Vol 48 ◽

pp. 31-35

Author(s):

R. B. Hanson

Keyword(s):

Error Estimates ◽

Zero Point ◽

Absolute Zero ◽

Apparent Magnitude ◽

Coherent System ◽

Preliminary Results ◽

General Catalogue ◽

Systematic Effects ◽

New Evidence ◽

Right Ascension

Several outstanding problems affecting the existing parallaxes should be resolved to form a coherent system for the new General Catalogue proposed by van Altena, as well as to improve luminosity calibrations and other parallax applications. Lutz has reviewed several of these problems, such as: (A) systematic differences between observatories, (B) external error estimates, (C) the absolute zero point, and (D) systematic observational effects (in right ascension, declination, apparent magnitude, etc.). Here we explore the use of cluster and spectroscopic parallaxes, and the distributions of observed parallaxes, to bring new evidence to bear on these classic problems. Several preliminary results have been obtained.

Download Full-text

MERLIN Finds New Evidence of Ranolazine Safety

Internal Medicine News ◽

10.1016/s1097-8690(07)70525-5 ◽

2007 ◽

Vol 40 (9) ◽

pp. 36

Author(s):

BRUCE JANCIN

Keyword(s):

New Evidence

Download Full-text

Vaccination for travellers – new evidence and recommendations

Therapeutische Umschau ◽

10.1024/0040-5930.58.6.362 ◽

2001 ◽

Vol 58 (6) ◽

pp. 362-366 ◽

Cited By ~ 2

Author(s):

Matius P. Stürchler ◽

R. P. Steffen

Keyword(s):

Hepatitis B ◽

Hepatitis A ◽

New Evidence

Impfungen sind einfache und effektive Maßnahmen zur Verhinderung von Reisekrankheiten. Compliance-Probleme sind gering, da alle Impfungen noch vor Abreise verabreicht werden und bei manchen Impfungen nur eine Dosis für den zuverlässigen Schutz nötig ist. Für jeden Reisenden sind die Hepatitis A- und die Diphtherie-Tetanus-Impfung empfohlen, für Asien und Afrika auch die Polioimpfung. Bei Reisen >30 Tagen, jüngeren Personen und Reisenden mit Risikoverhalten sollte immer auch eine Hepatitis B-Impfung, eventuell als Kombination mit Hepatitis A in Betracht gezogen werden. Je nach Reisestil, -destination und -dauer können auch weitere Impfungen wie z.B. die Typhus-, Tollwut-, Zeckenenzephalitis-, Grippe-, Masern-Mumps-Röteln-, Gelbfieber-, Meningokokkenmeningitis- und die Japanische Enzephalitis-Impfung in Frage kommen. Mehrere Impfungen können gleichzeitig verabreicht werden – eine Staffelung ist nicht nötig. i BAG Supplementum VI, Stand Juli 2000 «Impfungen für Auslandreisende»; http://www.admin.ch/bag/infekt/prev/reisemed/index.htm; Safetravel http://www.safetravel.ch; Tropimed

Download Full-text